Dong-A Pharm launches liquid-type human growth hormone grotropin-II injection
Published: 2003-12-10 06:59:00
Updated: 2003-12-10 06:59:00
Dong-A Pharm announced it has launched a liquid-type human growth hormone grotropin-II injection based on the EP standards for the first time in Korea after successful development of its formulation process in April 1999 via stability tests in July 1996.
According to the company's officials, t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.